Also trades as: 0K1R.L (LSE) · $vol 0M
VRDN NASDAQ
Viridian Therapeutics, Inc.
1W: -7.5%
1M: -7.2%
3M: +31.6%
YTD: -30.8%
1Y: +7.2%
3Y: +12.1%
5Y: +68.3%
$21.24
-1.05 (-4.71%)
Weekly Expected Move ±5.1%
$19
$20
$21
$22
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$20.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.4B
52W Range13.18-34.29
Volume943,151
Avg Volume2,231,892
Beta0.96
Dividend—
Analyst Ratings
Company Info
CEOStephen F. Mahoney
Employees252
SectorHealthcare
IndustryBiotechnology
IPO Date2014-06-18
Websiteviridiantherapeutics.com
221 Crescent Street
Waltham, MA 02453
US
Waltham, MA 02453
US
617 272 4600
About Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclonal anti-IGF-1R antibody currently advancing through Phase 1/2 clinical trials for thyroid eye disease (TED). The company's portfolio also features VRDN-002, an IGF-1R antibody undergoing Phase 1 clinical evaluation, alongside VRDN-003, a therapeutic antibody also designed to target IGF-1R for TED. Established in 2006, this Waltham, Massachusetts-based firm previously operated as Miragen Therapeutics, Inc., before changing its name to Viridian Therapeutics, Inc. in January 2021.
Latest News
27,472 Shares in Viridian Therapeutics, Inc. $VRDN Acquired by Jupiter Topco LLC
268,060 Shares in Viridian Therapeutics, Inc. $VRDN Acquired by Bank of New York Mellon Corp
Algert Global LLC Sells 81,762 Shares of Viridian Therapeutics, Inc. $VRDN
Deutsche Bank AG Invests $8.87 Million in Viridian Therapeutics, Inc. $VRDN
Arrowstreet Capital Limited Partnership Has $455,000 Stock Holdings in Viridian Therapeutics, Inc. $VRDN
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Tousignant Jennifer | S-Sale | 10,000 | $24.50 | 2026-08-19 |
| Tousignant Jennifer | M-Exempt | 10,000 | $14.41 | 2026-08-19 |
| Tousignant Jennifer | M-Exempt | 10,000 | $14.41 | 2026-08-19 |
| Tripuraneni Radhika | M-Exempt | 40,000 | $13.21 | 2026-08-14 |
| Tripuraneni Radhika | M-Exempt | 40,000 | $13.21 | 2026-08-14 |